Management of Sepsis in Patients with Cirrhosis

Antibiotic Choice and Dosing

Ceftriaxone is an appropriate first-line antibiotic choice for patients with cirrhosis and sepsis, as it covers approximately 95% of flora commonly isolated from patients with cirrhosis 1
The duration of antibiotic therapy should be 5-7 days, depending on clinical response, as recommended by the European Association for the Study of the Liver 1, 2

Maintain a restrictive packed red blood cell transfusion strategy (hemoglobin threshold of 7 g/dL, target 7-9 g/dL) to prevent increases in portal pressure, as suggested by the American Association for the Study of Liver Diseases 2
If the patient has gastrointestinal bleeding in addition to sepsis, continue vasoactive drugs (somatostatin, terlipressin, or octreotide) for 3-5 days alongside antibiotic therapy, as recommended by the European Association for the Study of the Liver 1
For patients with cirrhosis and gastrointestinal bleeding, ceftriaxone 1g daily for up to 7 days is recommended for prophylaxis, according to the American College of Gastroenterology 3

If sepsis is due to Spontaneous Bacterial Peritonitis (SBP), consider adding albumin (1.5 g/kg on day 1, followed by 1 g/kg on day 3) to prevent renal impairment, as recommended by the European Association for the Study of the Liver 4
Consider repeat diagnostic paracentesis in patients with SBP to document resolution of infection, as suggested by the British Society of Gastroenterology 4

Do not delay antibiotic escalation if clinical improvement is not observed within 48-72 hours, as recommended by the Infectious Diseases Society of America 5
Avoid unnecessary use of proton pump inhibitors in cirrhotic patients on antibiotics, as they may increase the risk of SBP, according to the American Gastroenterological Association 6

The European Association for the Study of the Liver recommends ceftriaxone, a closely related third-generation cephalosporin, as a first-line antibiotic for infections in cirrhosis, indicating cefuroxime is safe to use in cirrhotic patients 7, 8
Ceftriaxone 1g daily is specifically recommended for antibiotic prophylaxis in cirrhotic patients with gastrointestinal bleeding for up to 7 days, demonstrating the safety profile of cephalosporins in advanced liver disease 7, 8

The American Association for the Study of Liver Diseases suggests monitoring liver function tests at baseline and during therapy, particularly if using these antibiotics for prolonged courses, and watching for signs of hepatic encephalopathy, as any infection or medication can potentially precipitate this complication 7, 9

The Journal of Hepatology guidelines suggest shorter courses of antibiotics are preferred when clinically appropriate to minimize risk of adverse events 7